Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment

Europace

Volumn 13, Issue 5, 2011, Pages 640-645

  Hakalahti, Antti ^a   Uusimaa, Paavo ^a   Ylitalo, Kari ^a   Raatikainen, M J Pekka ^b  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Anticoagulation; Atrial fibrillation; Radiofrequency catheter ablation

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CATHETER ABLATION; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; TREATMENT OUTCOME; WARFARIN;

EID: 79955441513     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur038     Document Type: Article

References (28)

1. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6. (Pubitemid 39319000)
2. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657-63.
3. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/ Paisley study. Am J Med 2002;113:359-64. (Pubitemid 35223606)
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52. (Pubitemid 28446646)
5. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006;119:448e1-9.
6. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 12:1360-420.
7. Noheria A, Kumar A, Wylie JV Jr., Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med 2008;168:581-6. (Pubitemid 351468392)
8. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr. et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006;354: 934-41.
9. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
10. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5. (Pubitemid 40365469)
11. Dagres N, Hindricks G, Kottkamp H, Sommer P, Gaspar T, Bode K et al. Complications of atrial fibrillation ablation in a high-volume center in 1000 procedures: still cause for concern? J Cardiovasc Electrophysiol 2009;20:1014-9.
12. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol 2009;53:1798-803.
13. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007;9:335-79.
14. Natale A, Raviele A, Arentz T, Calkins H, Chen SA, Haissaguerre M et al. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007;18:560-80. (Pubitemid 46650353)
15. Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation 2007;116:2531-4. (Pubitemid 350179218)
16. Hussein AA, Martin DO, SalibaW, Patel D, Karim S, Batal O et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm 2009; 6:1425-9.
17. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation 121:2550-6.
18. Tolosana JM, Berne P, Mont L, Heras M, Berruezo A, Monteagudo J et al. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial. Eur Heart J 2009;30:1880-4.
19. Karjalainen PP, Vikman S, Niemela M, Porela P, Ylitalo A, Vaittinen MA et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J 2008;29:1001-10. (Pubitemid 351844686)
20. Lip GY, Frison L, Halperin JL, Lane DA. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010;41:2731-8.
21. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000;102:2619-28.
22. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest 138:1093-100.
23. Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE et al. Dual antiplatelet therapy and heparin 'bridging' significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 55:2376-82.
24. Annala AP, Karjalainen PP, Porela P, Nyman K, Ylitalo A, Airaksinen KE. Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment. Am J Cardiol 2008;102:386-90.
25. Bunch TJ, Crandall BG,Weiss JP, May HT, Bair TL, Osborn JS et al.Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol 2009;20:988-93.
26. Saliba W, Thomas J. Intracardiac echocardiography during catheter ablation of atrial fibrillation. Europace 2008;(Suppl 3):iii42-iii47.
27. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol 2005;16:474-7. (Pubitemid 40632478)
28. Wazni OM, Rossillo A, Marrouche NF, Saad EB, Martin DO, Bhargava M et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol 2005;16:576-81. (Pubitemid 40807645)